Top compounds associated with response to POTEE


Feature Type Standardized
Nominal ANOVA
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.036 0.4
mRNA RG-108 CTRPv2 pan-cancer AAC 0.034 0.4
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.4
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.035 0.4
mRNA piperlongumine CTRPv2 pan-cancer AAC 0.03 0.4
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.031 0.4
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.047 0.4
mRNA ML162 CTRPv2 pan-cancer AAC -0.031 0.4
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.045 0.4
Download CSV